Piramal Pharma strengthens future ready operations with 22.6% emissions reduction
Piramal Pharma, a leading global pharmaceuticals company, released its Sustainability Report 2025–26, showcasing significant…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Aurigene enters long-term manufacturing and supply partnership with a global pharma company
The counterparty's name has not been disclosed in view of confidentiality obligations under the agreement
BITS Pilani Goa researchers develop pharma polymer-based bioink for 3D-printed skin scaffolds and…
Study demonstrate a single, affordable hydrogel for tissue engineering and 3D-printed chewable tablets
India Pharma Archives launched at IIM Ahmedabad
Developed by IIM Ahmedabad Archives and supported by the Indian Pharmaceutical Alliance, India Pharma Archives captures the…
LSSSDC SkillVerse 2026 charts a new direction for skill development in the life sciences sector
100+ senior leaders from the life sciences industry participate in the national skill summit in Hyderabad
Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity
The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for…
Lupin signs exclusive licensing agreement for YUVEZZI in Europe
VISUfarma to undertake regulatory, commercialisation, marketing and distribution activities for YUVEZZI in 31 European markets
Glenmark launches Calcium Gluconate Injection USP in US
Glenmark introduces three Calcium Gluconate Injection USP presentations for the US market
ISHRAE successfully hosts PharmaConnect 2026 – Cleanroom Conclave in Mumbai
ISHRAE brings pharma, cleanroom and HVAC leaders together to shape the future of sustainable pharma manufacturing
Glenmark receives USFDA approval for Fluticasone Propionate Nasal Spray
Fluticasone Propionate Nasal Spray USP is bioequivalent and therapeutically equivalent to Flonase Nasal Spray
Strides Pharma receives USFDA EIR for Bengaluru facility
USFDA classifies inspection outcome as Voluntary Action Indicated following May 2026 cGMP inspection
Mankind Pharma inks agreement for two insulin analogues in India
Partnership with Chongqing Chenan Biopharmaceutical covers Insulin Degludec and Insulin Degludec + Aspart Combination
Invesco Mutual Fund launches India Pharma and Healthcare Fund
The open-ended equity scheme will invest across pharma, healthcare and allied sectors
Eppendorf introduces Research 3 neo pipette value packs
3-pack and 6-pack bundles are now available at a special rate for laboratories worldwide
India-US pharma ties look beyond generics
Sergio Gor, US Ambassador to India and Devendra Fadnavis, Maharashatra CM pitch deeper R&D, investment and co-development, at…
Dr Ashok Kumar Mittal elected to AIIMS Bathinda governing body
Rajya Sabha MP and Lovely Professional University Founder-Chancellor to contribute to the governance of the central healthcare and…
ACG appoints Lalit Kasliwal as Group Chief Financial Officer
Kasliwal to lead global finance, governance, capital allocation and risk management as ACG expands its international presence
An effective methodology for diabetes prediction in the case of class imbalance
Dr Vincent Hooper highlights how a machine learning methodology can improve diabetes prediction in clinical datasets affected by…
Godavari Biorefineries secures European patent for pharma composition
Patent covers a pharmaceutical composition combining anti-cancer compounds with a solubilising agent and the process to prepare it
Optimus Pharma gets DCGI permission for Tapinarof Cream 1% w/w
The company has received permission to manufacture and market Tapinarof Cream 1% w/w and the tapinarof bulk drug in India